People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists

Clinical trial NCT07207148 · RECRUITING

Trial details

NCT number: NCT07207148
Sponsor: Northwestern University
Status: RECRUITING
Study type: OBSERVATIONAL

Multiple Sclerosis

Start date: 2025-11-15
Primary completion: 2028-04-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.